Brief cognitive screening instruments for electroconvulsive therapy: Which one should I use?
Donel M MartinShawn M McClintockColleen K LooPublished in: The Australian and New Zealand journal of psychiatry (2020)
Electroconvulsive therapy is a highly effective treatment for pharmacoresistant and severe neuropsychiatric illness although cognitive side effects can be a barrier for treatment. Routine monitoring using brief cognitive screening instruments has advantages in busy clinical settings and can assist with optimising patient outcomes. More detailed neuropsychological assessment is recommended if the results from brief cognitive screening raise concerns.